Sign In
Buy CVSI
$0.0272
-0.0025 (-8.48%)
At Close: Jun 03, 2026
CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025
05:00pm, Friday, 08'th Aug 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 8, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in he
CV Sciences, Inc. Applauds Governor Abbot's Veto of Senate Bill 3
08:00pm, Monday, 23'rd Jun 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 23, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hem
CV Sciences, Inc. (CVSI) Q1 2025 Earnings Call Transcript
04:50pm, Wednesday, 14'th May 2025
CV Sciences, Inc. (OTCQB:CVSI) Q1 2025 - Earnings Conference Call May 14, 2025 4:00 PM ET Company Participants Brendan Hawkins - IR Joseph Dowling - CEO Joerg Grasser - CFO Conference Call Participant
CV Sciences, Inc. Reports First Quarter 2025 Financial Results
04:00pm, Wednesday, 14'th May 2025
SAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extract
CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025
06:30pm, Friday, 09'th May 2025
SAN DIEGO, CA / ACCESS Newswire / May 9, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts
CV Sciences, Inc. (CVSI) Q4 2024 Earnings Call Transcript
01:55pm, Thursday, 27'th Mar 2025
CV Sciences, Inc. (OTCQB:CVSI) Q4 2024 Earnings Conference Call March 27, 2025 10:00 AM ET Company Participants Brendan Hawkins - Investor Relations Joseph Dowling - Chief Executive Officer Joerg Gras
CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results
09:00am, Thursday, 27'th Mar 2025
SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extra
CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods
04:30pm, Wednesday, 26'th Mar 2025
The innovative product line offers a unique choice of plant-based, 100% natural alternatives to the foods everyone loves. SAN DIEGO, CA / ACCESS Newswire / March 26, 2025 / CV Sciences, Inc. (OTCQB:CV
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025
04:30pm, Thursday, 20'th Mar 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 20, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in he
CV Sciences Unveils New Aura Collection THC Fizz Tablets
09:00am, Wednesday, 05'th Feb 2025
The innovative, lemon-flavored fast-acting tablets provide a quick, uplifting experience, perfect for enhancing social moments or relaxing at home. SAN DIEGO, CA / ACCESS Newswire / February 5, 2025 /
CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs
04:30pm, Thursday, 21'st Nov 2024
SAN DIEGO , Nov. 21, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o
CV Sciences, Inc. (CVSI) Q3 2024 Earnings Call Transcript
01:13pm, Thursday, 14'th Nov 2024
CV Sciences, Inc. (OTCQB:CVSI) Q3 2024 Earnings Conference Call November 14, 2024 10:00 AM ET Company Participants Brendan Hawkins - Investor Relations Joseph Dowling - Chief Executive Officer Joerg G
CV Sciences, Inc. Reports Third Quarter 2024 Financial Results
09:00am, Thursday, 14'th Nov 2024
SAN DIEGO , Nov. 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o
CV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024
09:00am, Friday, 08'th Nov 2024
SAN DIEGO , Nov. 8, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and
CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements
09:00am, Tuesday, 27'th Aug 2024
Designed to elevate focus, mood, energy, and metabolism with clinically proven wellness ingredients Available in three variations - Clarity, Peace, and ReShape SAN DIEGO , Aug. 27, 2024 /PRNewswire/
